Valeant Pharmaceuticals International, Inc. Press Releases

VRX 
$141.46
*  
1.13
0.81%
Get VRX Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading VRX now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    VRX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance
12/15/2014 4:30:00 PM - PR Newswire
▲2.39 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neuberger Berman Real Estate Securities Income Fund Announces Monthly Distribution
11/28/2014 5:00:00 PM - PR Newswire


Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018
11/28/2014 5:00:00 PM - PR Newswire
▼-2.74 % Price Change since this news event. The Volume Ratio is 0.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris
11/25/2014 8:00:00 AM - PR Newswire


Investors Who Sold Allergan (AGN) Shares Between April 1, 2014 and April 21, 2014 May Contact Gardy & Notis, LLP Law Firm For Further Information
11/24/2014 2:46:00 PM - PR Newswire


Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program
11/20/2014 11:38:00 AM - PR Newswire


Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation
11/18/2014 8:00:00 AM - PR Newswire


Valeant Comments On Allergan Announcement
11/17/2014 9:29:00 AM - PR Newswire


Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey
11/13/2014 5:00:00 PM - PR Newswire
▲7.25 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Valeant Pharmaceuticals Sends Letter To Physician Customers
11/7/2014 5:00:00 PM - PR Newswire
▲12.27 % Price Change since this news event. The Volume Ratio is 0.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Valeant And Pershing Square May Vote At Special Meeting
11/4/2014 1:27:00 PM - PR Newswire
▲6.12 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Information on publication of financial reports according to sections 37 v, 37 w, 37 x and 37 y of the German Securities Trading Law (Wertpapier-Handelsgesetz, WpHG)
11/4/2014 1:26:00 PM - GlobeNewswire


Valeant Delivers Letter To Allergan Board
10/27/2014 6:55:00 AM - PR Newswire
▲9.55 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results
10/20/2014 7:00:00 AM - PR Newswire
▲17.79 % Price Change since this news event. The Volume Ratio is 1.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014
10/15/2014 9:17:00 AM - PR Newswire
▲25.19 % Price Change since this news event. The Volume Ratio is 1.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sirona Biochem: Obagi Medical Products Begins Manufacturing Scale-Up of Skin Lightening Agent
10/7/2014 7:45:00 AM - Market Wire


IGI Laboratories, Inc. Acquires Two Products From Valeant Pharmaceuticals
10/1/2014 8:00:00 AM - PR Newswire


Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA
9/30/2014 11:27:00 AM - PR Newswire